The Evolving Evidence-Based and Guideline-Supported Role for Nanoliposomal Topoisomerase Inhibitors in Metastatic Pancreatic Adenocarcinoma: 

The Evolving Evidence-Based and Guideline-Supported Role for Nanoliposomal Topoisomerase Inhibitors in Metastatic Pancreatic Adenocarcinoma: 


Published

Created by

CMEducation Resources symposium

Related Presenters

Johanna Bendell, MD

Johanna Bendell, MD

Chief Development Officer
Director, GI Oncology Research Program
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, TN